PotlatchDeltic Corporation (Nasdaq: PCH) announced today the tax treatment for its dividend distributions made in 2024 on the ...

US regulators have rejected a T cell therapy for a rare and serious transplant complication related to Epstein-Barr virus ...

Cytokinetics, Inc. (CYTK), a biopharmaceutical company focused on muscle biology, on Monday announced the launch of the AMBER-HFpEF ...

Treatment for CLL continues to change. Doctors are using newer targeted cancer drugs. This means a stem cell transplant is now a less common treatment for CLL. You have a transplant using donor cells ...

A2 Bio­ther­a­peu­tics has raised $80 mil­lion to run three ex­per­i­men­tal CAR-T pro­grams for sol­id tu­mor can­cers. The ...

EBBH-2024 is under clinical development by Essen Biotech and currently in Phase II for Refractory Chronic Lymphocytic Leukemia (CLL).

A flurry of executive orders that President Donald Trump signed into place Monday night included one that cemented language ...

Since her diagnosis at 19 years old, the social media star has documented her journey with synovial sarcoma, a rare form of ...

AT-19 is under clinical development by Shanghai YaKe Biotechnology and currently in Phase II for Chronic Lymphocytic Leukemia (CLL).

A coroner is demanding more action should be taken by an NHS Trust mental health service after a 13-year-old girl took her ...